SCHEMBL30911420

SCHEMBL30911420

CC(C)(C)OC(=O)NCCc1nc(C(F)(F)F)cc2c(Br)n[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ NQO2 P16083 1/20 0.39
▸ CACNA1H O95180 1/20 0.36
▸ CACNA1B Q00975 1/20 0.36
▸ CACNA1C Q13936 1/20 0.36
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ HTT P42858 1/20 0.34
▸ BCHE P06276 1/20 0.34
▸ IGF1R P08069 1/20 0.34
▸ SUV39H2 Q9H5I1 1/20 0.33
▸ PDE3B Q13370 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ LATS1 O95835 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35211066 0.80 NPSR1 (0.41) NPSR1ALDH1A1GFERNQO2CACNA1H
SCHEMBL30911374 0.80 CACNA1H (0.35) NPSR1ALDH1A1GFERCACNA1HCACNA1B
SCHEMBL35210855 0.76 SOS1 (0.35) CACNA1HCACNA1BCACNA1CCA1CA2
SCHEMBL35211335 0.76 SOS1 (0.35) CACNA1HCACNA1BCACNA1CCA1CA2
SCHEMBL30911387 0.73 NT5E (0.34) —
SCHEMBL30911360 0.69 NT5E (0.33) —
SCHEMBL31600640 0.67 LMNA (0.41) NPSR1ALDH1A1GFERNQO2CACNA1H
SCHEMBL1186965 0.66 CACNA1H (0.45) ALDH1A1NQO2CACNA1HCACNA1BCACNA1C
SCHEMBL6818984 0.66 CACNA1H (0.46) NPSR1ALDH1A1GFERCACNA1HCACNA1B
SCHEMBL31505359 0.66 NQO2 (0.47) NPSR1ALDH1A1GFERNQO2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125375-A1 SUBSTITUTED 1H-PYRAZOLO-PYRIDINE AND -PYRIMIDINE COMPOUNDS PFIZER INC. (US) 2026-05-07 — — US disclosed
WO-2024074977-A1 SUBSTITUTED 1 H-PYRAZOLO-PYRIDINE AND-PYRIMIDINE COMPOUNDS PFIZER INC. (US) 2024-04-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125375-A1 SUBSTITUTED 1H-PYRAZOLO-PYRIDINE AND -PYRIMIDINE COMPOUNDS CCR1, CCR6, CCRL2 NPSR1 1387/4885ALDH1A1 1665/4885GFER 3827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback